MedPath
Found 2 clinical trials|View Analysis
Sort by:

Early Initiation of Tafolecimab for Patients With Acute Coronary Syndromeundergoing Percutaneous Coronary Intervention in Chinese Population

Not Applicable
Not yet recruiting
Conditions
Acute Coronary Syndrome
Non ST Segment Elevation Acute Coronary Syndrome
Interventions
First Posted Date
2023-10-24
Last Posted Date
2023-10-24
Lead Sponsor
China National Center for Cardiovascular Diseases
Target Recruit Count
3684
Registration Number
NCT06096909

Plaque REgression With Cholesterol Absorption Inhibitor or Synthesis Inhibitor Evaluated by IntraVascular UltraSound

Phase 4
Completed
Conditions
Coronary Artery Disease
Hypercholesterolemia
Interventions
Drug: Lipitor (Atorvastatin) monotherapy
Drug: Combination therapy with Lipitor [Atorvastatin] and Zetia [Ezetimibe]
First Posted Date
2010-01-06
Last Posted Date
2015-04-01
Lead Sponsor
Kumamoto University
Target Recruit Count
245
Registration Number
NCT01043380
Locations
🇯🇵

Kumamoto University, Kumamoto, Japan

© Copyright 2025. All Rights Reserved by MedPath